Distribution of 1,2 DMH-induced colonic aberrant crypt foci after administration of a gastrin receptor antagonist (CR2945), in the murine model

Annali Italiani di Chirurgia

Volumn 72, Issue 2, 2001, Pages 221-225

  Fontana, M G ^a   Ghirardi, M ^a   Moneghini, D ^a   La Pinta, M ^a   Villanacci, V ^a   Donato, F ^a   Salerni, B ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Aberrant crypt foci (ACF); Colon cancer

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BENZODIAZEPINE DERIVATIVE; CARCINOGEN; CHOLECYSTOKININ RECEPTOR; ITRIGLUMIDE;

ANIMAL; ARTICLE; COLON; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; MALE; MOUSE; PATHOLOGY;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BENZODIAZEPINES; CARCINOGENS; COLON; COLONIC NEOPLASMS; MALE; MICE; RECEPTORS, CHOLECYSTOKININ;

EID: 0035292420     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Armitage P., Berry G.: Statistical methods in medical research. Blackwell Scientific Publication, Oxford, U.K. 1994.
2. Baldwin G.S., Shulles A.: Gastrin, gastrin receptors and colorectal carcinoma. Gut, 42:581-584, 1998.
3. Bird R.: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett, 37:147-151, 1987.
4. Bird R.: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett, 93:55-71, 1995.
5. Bold R.J., Warren R.E., Ishizuka J., Cho-Chung Y.S., Townsend C.M., Thompson J.C.: Experimental gene therapy of human colon cancer. Surgery, 116:186-196, 1994.
6. Bouzurene H., Chaubert P., Seelentag W., Bosman F. T., Saraga E.: Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease. Human Pathol, 30(1):66-71, 1999.
7. Dembinski A.B., Johnson L.R.: Growth of pancreas and gastrointestinal mucosa by secretin, cerulein and pentagastrin. Endocrinology, 106:323-328, 1980.
8. Dixon W.J., Brown M.B., Engelman L., Jenrich N.I. BDMP Statistical Software Manual. Los Angeles, CA, University of California Press, 1993.
9. Fontana M.G., Donato F., Villanacci V., Ghirardi M., Moneghini D., Di Betta E., Salerni B.: Inhibitory effect of a gastrin receptor antagonist, CR 2945, on 1,2 dimethylydrazine-induced colorectal cancer in mice. Eur Surg Res, 31:406-411, 1999.
10. Ghirardi M., Nascimbeni R., Villanacci V., Fontana M.G., Di Betta E., Salerni B.: Azoxymethane-induced aberrant crypt foci and colorectal cancer in F344 rats: sequential analysis of growth. Eur Surg Res, 31:272-280, 1999.
11. Hardmann W.E., Cameron I.L., Heitman D.W., Contreras E.: Demonstration of the need for end point validation of putative bio-markers: failure of aberrant cript foci to predict colon cancer incidence. Cancer Res, 51:6388-6392, 1991.
12. Imdhal A., Eggstein S., Crone L., Farthmann E.H.: Growth of colorectal carcinoma cells regulation in vitro gastrin, pentagastrin and the gastrin receptor antagonist proglumide. J Can Res Clin Oncol, 115:388-392, 1989.
13. Johnson L.R., Guthrie P.D.: Mucosal DNA synthesis: a short term index of the trophic action of gastrin. Gastroenterology, 67:453-459, 1974.
14. Johnson L.R.: The trophic action of gastrointestinal hormones. Gastroenterology, 70:278-288, 1976.
15. Johnson L.R.: New aspects of the trophic action of gastrointestinal hormones. Gastroenterology, 72:788-792, 1977.
16. La Mont J.T., O'Gorman T.A.: Experimental colon cancer. Gastroenterology, 75:1157-1169, 1978.
17. Mc Lellan E.A., Bird R.: Aberrant crypts: potential preneoplastic lesions the murine colon cancer. Cancer Res, 48:6187-6192, 1988.
18. Mc Lellan E.A., Medline A., Bird R.: Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis, 12:2093-2098, 1991.
19. Mc Williams D.F., Watson S.A., Crosbee D.M., Michaeli D., Seth R.: Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut, 42(6)795-798, 1998.
20. Morson B.C., Dawson I.M.P., Day D.W., Jass J.R., Price A.B., Williams G.T.: Gastrointestinal Pathology. Blackwell Scientific Pubblication, 1972.
21. Nakata H., Wang S.L., Chung D.C., Wesrwick J.K., Tillotson L.G.: Oncogenic Ras induces gastrin gene expression in colon cancer. Gastroenterology, 116:186-196, 1998.
22. Nemeth J., Taylor B., Paulwels S., Varro A., Dockray G.J.: Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut, 34:90-95, 1993.
23. Penman I.D., Mc Coll K.E.: Gastrin and colorectal cancer: where now? Eur J Gastroenterol Hepatol, 10(4):285-288, 1998.
24. Pretlow T.P., Barrow B.J., Ashton W.S., O'Riordan M.A., Pretlow T.G., Jurcisek J.A., Stellato T.A: Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res, 51:1564-1567, 1991.
25. Rae-Venter B., Townsend C.M., Thompson J.G., Simon P.M.: Gastrin receptors in human colonic carcinoma. Gastroenterology, 80:1256-1259, 1981.
26. Roncucci L., Stamp D., Medline A., Cullen J.B., Bruce W., R.: Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol, 22:287-294, 1991.
27. Roncucci L., Modica S., Pedroni M., Tamassia M.G., Ghidoni M., Losi L., Fante R., Di Gregorio C., Manenti A., Gafa L., Ponz De Leon M.: Aberrant crypt foci in patients with colorectal cancer. Br J Cancer, 77 (12):2343-2348, 1998.
28. Singh P., Rae-Venter B., Townsend C.M., Khalil T., Thompson J.C.: Gastrin receptors and malignant gastrointestinal mucosa: age associated changes. Am J Physiol, 249:6761-6769, 1985.
29. Singh P., Xu Z., Dai B., Rajaraman S., Rubin N., Dhruva B.: Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidate gastrins. Am J Physiol, G:459-468, 1994.
30. Singh P., Owalia A., Verro A., Dai B., Rajaraman S., Wood T.: Gastrin gene expression is required for the proliferation and tumorige-nicity of human colon cancer cells. Cancer Res, 56:4111-4115, 1996.
31. Siu I.M., Robinson D.R., Schwartz S., Kung H.J., Pretlow T.G., Petersen R.B., Pretlow T.P.: The identification of monoclonality in human aberrant crypt foci. Cancer Res, 59(1):63-66, 1999.
32. Svet-Moldawsky G.J.: Dependence of gastrointestinal tumors on gastrointestinal hormones: pentagastrin stimulates growth of transplanted colon adenocarcinoma in mice. Biomcdicine, 33:259-261, 1980.
33. Tahara E.: Growth factors and oncogenes in human gastrointestinal carcinoma. J. Cancer Res Clin Oncol, 115:388-392, 1989.
34. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Kato J., Kogawa K., Miyake H., Niitsu Y.: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med, 339(18):1277-1284, 1998.
35. Upp J.C., Singh P., Townsend C.M., Khalil T., Thompson J.C.: Clinical significance of gastrin receptors in human colon cancers. Cancer Res, 49:488-492, 1989.
36. Van Solinge W.W., Nielsen F.C., Friis Hansen L., Falkmer U.G., Rehfeld J.F.: Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology, 104:1099-1107, 1993.
37. Winsett O.E., Townsend C.M. Jr, Glass E.J., Rae Venter B., Thompson J.C.: Gastrin stimulates growth of colon cancer. Surg Forum, 33:384-396, 1982.